Seeking Alpha

CVS Caremark (CVS +9.2%) shares obviously benefit from its predicted double-digit profit...

CVS Caremark (CVS +9.2%) shares obviously benefit from its predicted double-digit profit increase in 2012 and 30% dividend hike, but it also touts the success of MinuteClinic, a wave of generics that is seen boosting profitability the next several years and customer wins if a contract spat between Walgreen (WAG) and Express Scripts (ESRX) continues into 2012.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector